{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T18:40:08Z","timestamp":1756320008133,"version":"3.44.0"},"reference-count":15,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2025,4,9]]},"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:p>A previously healthy professional athlete in his 20s, with no prior psychiatric or medical history, presented with a 4-day history of rapidly progressive neurological deterioration. This manifested as persistent stupor, mutism and profound psychomotor retardation, enduring several weeks with minimal improvement despite escalating doses of lorazepam (up to 14 mg\/day). Extensive investigations at a tertiary neurological centre in the UK revealed no identifiable organic cause. The patient\u2019s symptoms ameliorated promptly with the initiation of electroconvulsive therapy in conjunction with lorazepam.<\/jats:p>","DOI":"10.1136\/bcr-2024-263336","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T15:20:13Z","timestamp":1745335213000},"page":"e263336","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Unspecified catatonia presenting to neurology and psychiatry with no detectable organic aetiology"],"prefix":"10.1136","volume":"18","author":[{"given":"Eugene","family":"Wong","sequence":"first","affiliation":[{"name":"Psychiatry Department, Hairmyres Hospital, East Kilbride, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Busuttil","sequence":"additional","affiliation":[{"name":"Psychiatry Department, Hairmyres Hospital, East Kilbride, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"2025082711101865000_18.4.e263336.1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbx157"},{"key":"2025082711101865000_18.4.e263336.2","first-page":"280","article-title":"Catatonia: demographic, clinical and laboratory associations","volume":"51","author":"Rogers","year":"2021","journal-title":"Psychol Med"},{"key":"2025082711101865000_18.4.e263336.3","unstructured":"World Health Organization . International classification of diseases for mortality and morbidity statistics (11th revision). Geneva World Health Organization; 2019."},{"key":"2025082711101865000_18.4.e263336.4","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2014.00181"},{"key":"2025082711101865000_18.4.e263336.5","doi-asserted-by":"publisher","DOI":"10.1080\/000486700373"},{"key":"2025082711101865000_18.4.e263336.6","doi-asserted-by":"publisher","DOI":"10.1017\/S0140525X02000109"},{"key":"2025082711101865000_18.4.e263336.7","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.21.4.371"},{"key":"2025082711101865000_18.4.e263336.8","doi-asserted-by":"publisher","DOI":"10.1177\/02698811231158232"},{"key":"2025082711101865000_18.4.e263336.9","first-page":"301","article-title":"Diagnosis and management of catatonia: a case-based review","volume":"83","author":"McEvoy","year":"2003","journal-title":"Schizophr Res"},{"key":"2025082711101865000_18.4.e263336.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(96)00378-2"},{"key":"2025082711101865000_18.4.e263336.11","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2147\/NDT.S231573","article-title":"Electroconvulsive Therapy for Patients with Catatonia: Current Perspectives","volume":"16","author":"Lloyd","year":"2020","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2025082711101865000_18.4.e263336.12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","article-title":"Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis","volume":"361","year":"2003","journal-title":"The Lancet"},{"key":"2025082711101865000_18.4.e263336.13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/HRP.0000000000000365","article-title":"Electroconvulsive Therapy: Mechanisms of Action, Clinical Considerations, and Future Directions","volume":"31","author":"Kritzer","year":"2023","journal-title":"Harv Rev Psychiatry"},{"key":"2025082711101865000_18.4.e263336.14","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181c9bfe6"},{"key":"2025082711101865000_18.4.e263336.15","first-page":"41","article-title":"The pharmacotherapy of catatonia","volume":"17","author":"Carroll","year":"2010","journal-title":"Prim Psychiatry"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2024-263336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T18:10:23Z","timestamp":1756318223000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2024-263336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,22]]},"published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1136\/bcr-2024-263336"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2024-263336","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2025,4]]}}}